Eikon Therapeutics, Inc. Common Stock (EIKN) Financials

Eikon Therapeutics, Inc. Common Stock (EIKN) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.

Financials — source: SEC XBRL
Price / Book1.32
FCF Yield-75.8%
Sector P/E (Healthcare)21.7

EIKN overview · EIKN earnings · EIKN KPIs · EIKN investor relations · EIKN ownership · EIKN peers · EIKN filings

Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.